Integrated Filing- Financial

Lasa Supergenerics held a board meeting on August 14, 2026, where it approved the financial results for the quarter ended June 30, 2026. 1. **Financial Performance:** The company's operations remain severely impacted by a major fire in May 2025 at its primary, uninsured factory.

This incident continues to halt all production, significantly impacting revenue-generating capacity.

2. **Profitability and EPS:** The company previously recognized an uninsured fire loss of **Rs. 20.57 Cr**. Ongoing operational challenges, including a labor union strike preventing access for damage assessment, continue to impact financial stability.

Government grant income recognition is suspended.

3. **Growth Drivers & Expense Trends:** Inability to resume manufacturing and assess the full extent of asset damage creates substantial hurdles.

The company also faces significant contingent liabilities from GST demands totaling **Rs. 38.11 Cr**. 4. **Final Lens for Investors:** Overall, these results reflect very weak financial momentum and significant uncertainty.